ALABX
Price
$13.25
Change
+$0.04 (+0.30%)
Updated
Oct 17 closing price
Net Assets
12.72M
RLBBX
Price
$38.66
Change
+$0.03 (+0.08%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

ALABX vs RLBBX

Header iconALABX vs RLBBX Comparison
Open Charts ALABX vs RLBBXBanner chart's image
ALPS/Smith Balanced Opportunity A
Price$13.25
Change+$0.04 (+0.30%)
VolumeN/A
Net Assets12.72M
American Funds American Balanced R2
Price$38.66
Change+$0.03 (+0.08%)
VolumeN/A
Net Assets265.37B
ALABX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
ALABX vs. RLBBX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALABX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 265B vs. ALABX (12.7M). ALABX pays higher dividends than RLBBX: ALABX (1.55) vs RLBBX (1.11). ALABX was incepted earlier than RLBBX: ALABX (5 years) vs RLBBX (23 years). ALABX (2.63) is less costly to investors than RLBBX (1.32). ALABX is a more actively managed with annual turnover of: 131.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than ALABX: RLBBX (250) vs ALABX (2500). RLBBX annual gain was more profitable for investors over the last year : 7.84 vs. ALABX (-0.62). ALABX (38.09) and RLBBX (37.69) have equivalent 5 years return.
ALABXRLBBXALABX / RLBBX
Total Expense Ratio1.151.3287%
Annual Report Gross Expense Ratio2.631.32199%
Fund Existence5 years23 years-
Gain YTD9.54513.93868%
Front Load3%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.7M265B0%
Annual Yield % from dividends1.551.11140%
Returns for 1 year-0.627.84-8%
Returns for 3 years38.5047.4381%
Returns for 5 years38.0937.69101%
Returns for 10 years25.9367.6438%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PKBK20.200.33
+1.66%
Parke Bancorp
TDG1265.8816.46
+1.32%
TransDigm Group
SR85.350.48
+0.57%
Spire
MNTN15.03-0.02
-0.13%
MNTN Inc.
NRSN1.19-0.03
-2.46%
NeuroSense Therapeutics Ltd